This website uses cookies. By continuing to browse this website you are agreeing to our use of cookies. Find out more by reading our privacy policy. Read more
Novo Nordisk A/S : Status regarding Novo Nordisk's holding of its own shares (1 October 2012)
| Read the full announcement in PDF format |
In continuation of the company's announcements dated 2 May 2012 and 9 August 2012 concerning planned share repurchase programmes, and pursuant to Section 204.25 of the New York Stock Exchange Listed Company Manual, this is to report that Novo Nordisk A/S (NYSE: NVO) and its wholly-owned affiliates on 30 September 2012 owned 16,374,105 of its own B shares of DKK 1, corresponding to a total nominal value of DKK 16,374,105 or 2.9% of the total share capital.
| Media: | Investors: |
| Anne Margrethe Hauge | Kasper Roseeuw Poulsen |
| Tel: (+45) 4442 3450 | Tel: (+45) 4442 4303 |
| amhg@novonordisk.com | krop@novonordisk.com |
| Frank Daniel Mersebach | |
| Tel: (+45) 4442 0604 | |
| fdni@novonordisk.com | |
| Lars Borup Jacobsen | |
| Tel: (+45) 3075 3479 | |
| lbpj@novonordisk.com | |
| In North America: | |
| Ken Inchausti | Jannick Lindegaard |
| Tel: (+1) 609 514 8316 | Tel: (+1) 609 786 4575 |
| kiau@novonordisk.com | jlis@novonordisk.com |
Company Announcement no 62 / 2012
